Tsumura & Co. (4540.T)

JPY 4759.0

(-0.69%)

Total Debt Summary of Tsumura & Co.

  • Tsumura & Co.'s latest annual total debt in 2023 was 79.69 Billion JPY , down 0.0% from previous year.
  • Tsumura & Co.'s latest quarterly total debt in 2024 Q1 was 79.69 Billion JPY , down 0.0% from previous quarter.
  • Tsumura & Co. reported annual total debt of 79.69 Billion JPY in 2022, up 60.37% from previous year.
  • Tsumura & Co. reported annual total debt of 49.69 Billion JPY in 2021, down -5.98% from previous year.
  • Tsumura & Co. reported quarterly total debt of 79.69 Billion JPY for 2023 Q4, down 0.0% from previous quarter.
  • Tsumura & Co. reported quarterly total debt of 79.69 Billion JPY for 2023 FY, down 0.0% from previous quarter.

Annual Total Debt Chart of Tsumura & Co. (2023 - 2004)

Historical Annual Total Debt of Tsumura & Co. (2023 - 2004)

Year Total Debt Total Debt Growth
2023 79.69 Billion JPY 0.0%
2022 79.69 Billion JPY 60.37%
2021 49.69 Billion JPY -5.98%
2020 52.85 Billion JPY -19.02%
2019 65.26 Billion JPY 31.35%
2018 49.69 Billion JPY -23.19%
2017 64.69 Billion JPY 75.04%
2016 36.95 Billion JPY 0.0%
2015 36.95 Billion JPY 0.0%
2014 36.95 Billion JPY 68.32%
2013 21.95 Billion JPY 0.0%
2012 21.95 Billion JPY 0.0%
2011 21.95 Billion JPY -4.36%
2010 22.95 Billion JPY -0.69%
2009 23.11 Billion JPY -8.76%
2008 25.33 Billion JPY -14.33%
2007 29.57 Billion JPY -16.83%
2006 35.55 Billion JPY -25.08%
2005 47.45 Billion JPY -13.72%
2004 55 Billion JPY 0.0%

Peer Total Debt Comparison of Tsumura & Co.

Name Total Debt Total Debt Difference
Pharma Foods International Co., Ltd. 16.89 Billion JPY -371.79%
Takeda Pharmaceutical Company Limited 4843.75 Billion JPY 98.355%
Sumitomo Pharma Co., Ltd. 418.88 Billion JPY 80.976%
Shionogi & Co., Ltd. 11.62 Billion JPY -585.8%
Wakamoto Pharmaceutical Co.,Ltd. 100.52 Million JPY -79170.658%
Nippon Shinyaku Co., Ltd. 2.87 Billion JPY -2674.721%
Kaken Pharmaceutical Co., Ltd. 3.85 Billion JPY -1969.87%
Eisai Co., Ltd. 206.74 Billion JPY 61.455%
Morishita Jintan Co., Ltd. 425 Million JPY -18650.588%
Hisamitsu Pharmaceutical Co., Inc. 2.1 Billion JPY -3694.762%
Mochida Pharmaceutical Co., Ltd. 369 Million JPY -21496.206%
Fuso Pharmaceutical Industries,Ltd. 12.72 Billion JPY -526.395%
Nippon Chemiphar Co., Ltd. 16.98 Billion JPY -369.289%
Kissei Pharmaceutical Co., Ltd. 1.72 Billion JPY -4514.36%
Torii Pharmaceutical Co., Ltd. 244 Million JPY -32559.836%
Towa Pharmaceutical Co., Ltd. 202.35 Billion JPY 60.619%
Fuji Pharma Co., Ltd. 28.94 Billion JPY -175.287%
Zeria Pharmaceutical Co., Ltd. 47.58 Billion JPY -67.466%
KYORIN Holdings, Inc. 20.94 Billion JPY -280.455%
Taiko Pharmaceutical Co.,Ltd. 3.8 Billion JPY -1992.15%
Daito Pharmaceutical Co.,Ltd. 8.71 Billion JPY -813.981%
SymBio Pharmaceuticals Limited - JPY -Infinity%
MedRx Co., Ltd - JPY -Infinity%
Mizuho Medy Co.,Ltd. - JPY -Infinity%
Solasia Pharma K.K. 60 Million JPY -132716.667%
Modalis Therapeutics Corporation 412.5 Million JPY -19218.788%
ASKA Pharmaceutical Holdings Co.,Ltd. 9.48 Billion JPY -740.169%
Sawai Group Holdings Co., Ltd. 82.89 Billion JPY 3.861%
Cyfuse Biomedical K.K. 913 Million JPY -8628.368%
Toho Holdings Co., Ltd. 30.24 Billion JPY -163.49%
Koa Shoji Holdings Co.,Ltd. 2.82 Billion JPY -2720.597%